Evertex Fabrinology Ltd. AI Stock Analysis
Evertex Fabrinology Ltd. (1470) AI Stock Analysis
Evertex Fabrinology Ltd.
(TWSE:1470)
Evertex Fabrinology scores well on financial resilience: a near debt-free balance sheet, equity funding close to 90% of assets, and operating cash flow comfortably above reported profits give it strong downside protection in a cyclical industry. Offsetting this are erratic revenue, a notable drop in 2025 net income and EBITDA from elevated 2024 levels, and a modest 6.6% return on equity that points to an underworked capital base. Technically, the stock has slipped below its short-term moving averages with a negative MACD, signalling fading momentum despite a still-intact longer-term uptrend and very low volatility. Valuation is fair-to-full at 18.1x earnings, though a 2.8% dividend yield supported by free cash flow adds some appeal. The result is a stable, low-risk holding that still needs to demonstrate more consistent growth and better returns on capital.
Evertex Fabrinology Ltd. (1470) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 2.00B
- Dividend Yield
- 2.78%
- Average Volume (3M)
- 13.82K
- Price to Earnings (P/E)
- 18.1
- Beta (1Y)
- 0.11
- Revenue Growth
- -7.41%
- EPS Growth
- 128.29%
- Country
- TW
- Employees
- 264
- Sector
- General
- Sector Strength
- 55
- Industry
- Manufacturing - Textiles
Evertex Fabrinology Ltd. Business Overview & Revenue Model
Company Description
Evertex Fabrinology Limited is a company that specializes in the global manufacturing and distribution of various textile products. Their extensive product line features several distinct materials, including Janerino, a unique hybrid merino wool fabr...
Evertex Fabrinology Ltd. Financial Statement Overview
Summary
A very strong balance sheet (score 86) anchors the profile: debt-to-equity of just 0.04, equity funding roughly 87% of assets, and essentially no solvency or refinancing risk. Cash flow (76) is solid, with 2025 operating cash flow of NT$117.7M exceeding net income by about 1.75x and free cash flow of NT$78.6M, though capex lumpiness makes FCF uneven. The income statement (61) is the weak link: revenue is cyclical (NT$894.8M in 2021 to NT$655.2M in 2023, recovering to NT$803.7M in 2025) and 2025 net income fell to NT$67.3M from NT$97.3M, with net margin compressing to 8.4% and EBITDA margin dropping to 16.2%. Multi-year gross margin expansion to 24.2% is a genuine positive, but mid-single-digit ROE of 6.6% suggests an underutilized capital base.
Income Statement
61PositiveBalance Sheet
86Very PositiveCash Flow
76Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 762.71M | 803.71M | 788.04M | 655.22M | 845.15M | 894.79M |
| Gross Profit | 199.42M | 194.40M | 199.38M | 129.82M | 174.32M | 191.12M |
| EBITDA | 153.10M | 130.20M | 172.19M | 108.43M | 103.25M | 135.18M |
| Net Income | 111.42M | 67.27M | 97.31M | 49.35M | 32.84M | 65.20M |
Balance Sheet | ||||||
| Total Assets | 1.21B | 1.16B | 1.21B | 1.15B | 1.14B | 1.25B |
| Cash, Cash Equivalents and Short-Term Investments | 422.00M | 378.57M | 406.78M | 445.31M | 410.96M | 358.38M |
| Total Debt | 43.67M | 42.03M | 54.30M | 54.80M | 53.12M | 106.41M |
| Total Liabilities | 198.01M | 146.85M | 177.46M | 160.10M | 171.85M | 248.93M |
| Stockholders Equity | 1.01B | 1.01B | 1.03B | 985.32M | 972.98M | 1.01B |
Cash Flow | ||||||
| Free Cash Flow | 101.50M | 78.61M | 84.96M | 110.62M | 162.17M | -1.32M |
| Operating Cash Flow | 148.37M | 117.75M | 111.35M | 144.74M | 189.18M | 43.83M |
| Investing Cash Flow | -49.93M | -77.52M | 33.65M | -90.19M | -61.95M | 34.48M |
| Financing Cash Flow | -98.46M | -98.67M | -58.89M | -42.22M | -72.17M | -39.92M |
Evertex Fabrinology Ltd. Peers Comparison
Overall Rating
TW:147068Neutral
TW:132351Neutral
TW:146851Neutral
TW:994450Neutral
TW:146741Neutral
TW:893539Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | TWD 2.00B | 18.10 | ― | 2.78% | -7.41% | 128.29% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 51Neutral | TWD 1.99B | 17.24 | ― | 4.11% | -3.86% | -37.34% | |
| 51Neutral | TWD 2.17B | 15.34 | ― | ― | -39.42% | 466.76% | |
| 50Neutral | TWD 1.81B | 24.80 | ― | 1.76% | 10.50% | ― | |
| 41Neutral | TWD 1.80B | 29.61 | ― | ― | 1.24% | ― | |
| 39Underperform | TWD 1.96B | -30.27 | ― | ― | -13.84% | 12.29% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1470 | Evertex Fabrinology Ltd. | 23.35 | 1.25 | 5.64% | |
| TW:1323 | Yonyu Plastics Co., Ltd | 21.90 | 3.19 | 17.05% | |
| TW:1467 | Tex-Ray Industrial Co., Ltd. | 7.70 | 0.59 | 8.30% | |
| TW:1468 | Chang-Ho Fibre Corp. | 13.50 | 2.05 | 17.90% | |
| TW:8935 | Pontex Polyblend Co. Ltd. | 17.30 | -1.65 | -8.71% | |
| TW:9944 | Shinih Enterprise Co., Ltd. | 17.05 | 0.63 | 3.84% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
